Iranian Journal of Blood and Cancer

Aims & Scope

IJBC tries to provide a new opportunity for advancing the field of Hematology and Oncology in Iran and make a bridge between Iranian researchers and fellow scientists globally.

This journal is published in print and online and includes high quality manuscripts including basic and clinical investigations of blood disorders and malignant diseases namely: diagnosis, treatment, epidemiology, etiology, biology and molecular aspects as well as clinical genetics of these diseases, as they affect children, adolescents and adults. “IJBC” also includes the studies on transfusion medicine, hematopoietic stem cell transplantation, immunology, genetics and gene-therapy and accepts original papers, systematic reviews, case reports, brief reports and letters to the editor in all aspects of blood transfusion, blood donors recruitment, screening techniques, modern approaches to transfusion, whole blood and blood components applications.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Applications of nanofibers in the diagnosis and treatment of cancer

  Citation: 12

  Authors: Seyedeh Mahdieh, Asadollah, Aida, Arash, Deepak

• Gold nanoparticles in radiation therapy: an old story yet mesmerizing

  Citation: 4

  Authors: Yasamin, Mohadeseh Mohammadi, Mahdieh, Fereshteh

• Guideline for the diagnosis and treatment of hypothyroidism and hypoparathyroidism in patients with blood transfusion-dependent thalassemia

  Citation: 3

  Authors: Nahid, Neda, Mohammad E., Pooya, Mojtaba, Fariba, Negin, Mohammad Reza, Seyyed Morteza, Mohammad Javad, Mahdi, Mohammad Reza, Elham, Mohammad

• Plant-derived natural compounds as promising anticancer agents in hematological malignancies

  Citation: 2

  Authors: Forouzan, Shima, Atieh, Davood

• The Iranian Childhood Cancer Biobank

  Citation: 2

  Authors: Peyman, Nasrin, Maryam, Yalda, Mohsen, Zahra, Hamid, Mehran, Hasan Reza, Ehsan, Samin, Leily, Shahin, Ahmad, Javad, Nader, Mehdi, Reza, Paria, Parastoo

• NLR, PLR, and HPR as novel diagnostic biomarkers for Acute Lymphoblastic Leukemia

  Citation: 1

  Authors: Bahareh, Ahmad, Hossein, Fatemeh, Narjes, Fatemeh, Sepideh, Mohammadreza

• Is Dietary Pattern Associated with Gastric Cancer Risk? A Case-control Study in Iran

  Citation: 1

  Authors: Zeinab, Mohammad Hossein, Mohammad, Shahnaz, Elnaz

• The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation

  Citation: 1

  Authors: Seyed H., Ebrahim, Mohammad, Davood, Parisa, Ahmadreza, Elham, Marjan, Roghieh, Andisheh ie, Atieh, Seyed A., Kamran, Ardeshir

• CD38 gene polymorphisms and genetic susceptibility to chronic lymphocytic leukemia

  Citation: 1

  Authors: Morteza, Hadi, Shahrbano, Bahman

• Recurrent Pneumothorax and Pneumomediastinum as a Complication of COVID-19 in a Young Athlete

  Citation: 1

  Authors: Soha, Sina, Hadi, Mahdi, Mojtaba